fluorodeoxyglucose f18 has been researched along with propentofylline in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghaemi, M; Heiss, WD; Herholz, K; Kessler, J; Kittner, B; Mielke, R; Szelies, B | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and propentofylline
| Article | Year |
|---|---|
Propentofylline enhances cerebral metabolic response to auditory memory stimulation in Alzheimer's disease.
Topics: Acoustic Stimulation; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Brain; Double-Blind Method; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Memory; Middle Aged; Neuroprotective Agents; Prospective Studies; Psychometrics; Tomography, Emission-Computed; Xanthines | 1998 |